JAIN NIKUNJ

PrivateCIK: 2089213
Location

RICHMOND, CA

JAIN NIKUNJ enters SANGAMO THERAPEUTICS, INC with 253K shares plus derivative instruments

Holding both equity and derivatives at entry signals strong long-term conviction in the company.

Direct Derivatives
InsiderJAIN NIKUNJCIK 2089213
IssuerSANGAMO THERAPEUTICS, INCCIK 1001233
Officer· Principal Accounting Officer
Since Feb 2026
253K
Baseline shares
100% direct
253K
Direct ownership
1 position
233.45K
Derivative underlying
6 instruments
1
Security positions
All direct
Non-Derivative Holdings1

Common Stock

Direct
Shares owned253K
Total
253K direct253K
Derivative Holdings6

Stock Option (Right to Buy)

Direct
Underlying security
Common Stock

Underlying shares

11.89K

Shares owned

N/A

Exercise price

8.77

Expiration

Exercise window

Stock Option (Right to Buy)

Direct
Underlying security
Common Stock

Underlying shares

45.61K

Shares owned

N/A

Exercise price

8.77

Expiration

Exercise window

Stock Option (Right to Buy)

Direct
Underlying security
Common Stock

Underlying shares

24.75K

Shares owned

N/A

Exercise price

5.90

Expiration

Exercise window

Stock Option (Right to Buy)

Direct
Underlying security
Common Stock

Underlying shares

48.51K

Shares owned

N/A

Exercise price

2.66

Expiration

Exercise window

Stock Option (Right to Buy)

Direct
Underlying security
Common Stock

Underlying shares

3.24K

Shares owned

N/A

Exercise price

2.66

Expiration

Exercise window

Stock Option (Right to Buy)

Direct
Underlying security
Common Stock

Underlying shares

99.45K

Shares owned

N/A

Exercise price

0.9561

Expiration

Exercise window

Total

Underlying

233.45K

Owned

0.00

JAIN NIKUNJ — Initial Ownership Disclosure (Form 3) Filed Oct 9, 2025 | Finecho